ARDX
Ardelyx, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-19
Figures on this page computed 2026-11-08 12:48 UTC
Last close
2.99USD
Market data, 2026-11-05
Except where said otherwise: 10-K for 2025, filed 2026-02-19
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-19
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
-15.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
-10.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
- 10-K for 2025, filed 2026-02-19
- 10-K for 2025, filed 2026-02-19
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
- 10-K for 2025, filed 2026-02-19
- 10-Q for 2025, filed 2026-11-03
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth121.9%61 of 100, above its sector
- Returns on capital-36.9%25 of 100, above its sector
- Margins90.3%46 of 100, above its sector
- Price4.2x39 of 100, above its sector
- Safety4.3152 of 100, at its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
1 yes of 4 answered- 1Does it earn money?no
net margin, read above 0.
- 2Can it pay what it owes?Not known
interest coverage, read above 3. We do not hold that figure for this company.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?no
fcf margin, read above 0.
- 5Is it issuing shares?no
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?Not known
pe ratio, read below 20. We do not hold that figure for this company.
2 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.
1 of 4 questions answered yes; 2 could not be answered.
1 of 4 questions answered yes; 2 could not be answered.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-19
Does it earn money?-15.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
Can it pay what it owes?n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
Is it bigger than five years ago?121.9%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
Does the profit turn into cash?-10.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
Is it issuing shares?2.5%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD
Is it priced under twenty times earnings?n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437402-26-000013
- Reported in
- USD